BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 7970707)

  • 1. Activation of the E2F transcription factor by cyclin D1 is blocked by p16INK4, the product of the putative tumor suppressor gene MTS1.
    Schulze A; Zerfass K; Spitkovsky D; Henglein B; Jansen-Dürr P
    Oncogene; 1994 Dec; 9(12):3475-82. PubMed ID: 7970707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity.
    Johnson DG
    Oncogene; 1995 Nov; 11(9):1685-92. PubMed ID: 7478595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
    Oswald F; Lovec H; Möröy T; Lipp M
    Oncogene; 1994 Jul; 9(7):2029-36. PubMed ID: 8208548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression.
    Hiyama H; Iavarone A; LaBaer J; Reeves SA
    Oncogene; 1997 May; 14(21):2533-42. PubMed ID: 9191053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
    Kiess M; Gill RM; Hamel PA
    Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential activation of cyclin and cyclin-dependent kinase genes by adenovirus E1A12S cDNA product.
    Ishii T; Shimizu M; Kanayama Y; Nakada S; Nojima H; Oda K
    Exp Cell Res; 1993 Oct; 208(2):407-14. PubMed ID: 8375470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
    Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
    Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site.
    Schulze A; Zerfass K; Spitkovsky D; Middendorp S; Bergès J; Helin K; Jansen-Dürr P; Henglein B
    Proc Natl Acad Sci U S A; 1995 Nov; 92(24):11264-8. PubMed ID: 7479977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct interaction of p21 cyclin-dependent kinase inhibitor with the retinoblastoma tumor suppressor protein.
    Nakanishi M; Kaneko Y; Matsushime H; Ikeda K
    Biochem Biophys Res Commun; 1999 Sep; 263(1):35-40. PubMed ID: 10486249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter.
    Spitkovsky D; Schulze A; Boye B; Jansen-Dürr P
    Cell Growth Differ; 1997 Jun; 8(6):699-710. PubMed ID: 9186003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of E2F-1 by cyclin A-cdk2.
    Kitagawa M; Higashi H; Suzuki-Takahashi I; Segawa K; Hanks SK; Taya Y; Nishimura S; Okuyama A
    Oncogene; 1995 Jan; 10(2):229-36. PubMed ID: 7838523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F.
    Leone G; DeGregori J; Sears R; Jakoi L; Nevins JR
    Nature; 1997 May; 387(6631):422-6. PubMed ID: 9163430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deregulation of specific E2F complexes by the v-mos oncogene.
    Afshari CA; Rhodes N; Paules RS; Mudryj M
    Oncogene; 1997 Jun; 14(25):3029-38. PubMed ID: 9223666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of p16 in the E2F-dependent thymidine kinase regulation.
    Hengstschläger M; Hengstschläger-Ottnad E; Pusch O; Wawra E
    Oncogene; 1996 Apr; 12(8):1635-43. PubMed ID: 8622883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between E2F-1 requirement in the S phase and E2F-1 transactivation of cell cycle-related genes in human cells.
    Sala A; Nicolaides NC; Engelhard A; Bellon T; Lawe DC; Arnold A; Graña X; Giordano A; Calabretta B
    Cancer Res; 1994 Mar; 54(6):1402-6. PubMed ID: 8137237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of expression and activity of distinct pRB, E2F, D-type cyclin, and CKI family members during terminal differentiation of P19 cells.
    Gill RM; Slack R; Kiess M; Hamel PA
    Exp Cell Res; 1998 Oct; 244(1):157-70. PubMed ID: 9770359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases.
    Wang H; Shao N; Ding QM; Cui J; Reddy ES; Rao VN
    Oncogene; 1997 Jul; 15(2):143-57. PubMed ID: 9244350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-myc-enhanced S phase entry in keratinocytes is associated with positive and negative effects on cyclin-dependent kinases.
    Alexandrow MG; Moses HL
    J Cell Biochem; 1998 Sep; 70(4):528-42. PubMed ID: 9712150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of a cAMP pathway and induction of melanogenesis correlate with association of p16(INK4) and p27(KIP1) to CDKs, loss of E2F-binding activity, and premature senescence of human melanocytes.
    Haddad MM; Xu W; Schwahn DJ; Liao F; Medrano EE
    Exp Cell Res; 1999 Dec; 253(2):561-72. PubMed ID: 10585280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta regulation of retinoblastoma gene product and E2F transcription factor during cell cycle progression in mouse fibroblasts.
    Kim TA; Ravitz MJ; Wenner CE
    J Cell Physiol; 1994 Jul; 160(1):1-9. PubMed ID: 8021288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.